MS MA - Ansell Pres Unit

ANSLF Stock  USD 21.00  0.00  0.00%   

Insider

MS MA is Pres Unit of Ansell Limited
Phone61 3 9270 7229
Webhttps://www.ansell.com

Ansell Management Efficiency

The company has return on total asset (ROA) of 0.0605 % which means that it generated a profit of $0.0605 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1024 %, meaning that it generated $0.1024 on every $100 dollars invested by stockholders. Ansell's management efficiency ratios could be used to measure how well Ansell manages its routine affairs as well as how well it operates its assets and liabilities.
Ansell Limited has accumulated 426.3 M in total debt with debt to equity ratio (D/E) of 0.31, which is about average as compared to similar companies. Ansell Limited has a current ratio of 2.68, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Ansell until it has trouble settling it off, either with new capital or with free cash flow. So, Ansell's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ansell Limited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ansell to invest in growth at high rates of return. When we think about Ansell's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Aurelio SahagunStraumann Holding AG
50
Carla BurigattoHaemonetics
N/A
Angela CPAAtriCure
46
Marilee MBAAkoya Biosciences
65
Holger HadererStraumann Holding AG
54
KokKien LohStraumann Holding AG
56
B OwensAptarGroup
66
Tonya SPHRAtriCure
50
Joseph DriscollAkoya Biosciences
59
Brian CaseRepro Med Systems
51
Lloyd JohnsonHaemonetics
66
CCEP CCEPAtriCure
52
Clifford HoytAkoya Biosciences
N/A
Garry NolanAkoya Biosciences
62
Josh BennettRepro Med Systems
N/A
Kimberly ChaineyAptarGroup
48
Yury GoltsevAkoya Biosciences
N/A
Frederic PlaAkoya Biosciences
65
Matthew DellaMariaAptarGroup
N/A
Alastair RobertsonStraumann Holding AG
63
Tom AdamsRepro Med Systems
N/A
Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. Ansell Limited was founded in 1893 and is based in Richmond, Australia. Ansell operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 14000 people. Ansell Limited [ANSLF] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

Ansell Limited Leadership Team

Elected by the shareholders, the Ansell's board of directors comprises two types of representatives: Ansell inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ansell. The board's role is to monitor Ansell's management team and ensure that shareholders' interests are well served. Ansell's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ansell's outside directors are responsible for providing unbiased perspectives on the board's policies.
BA ACMA, CEO MD
Zubair Javeed, Chief Officer
Darryl Nazareth, Senior Vice President - Research and Development, Industrial Global Business Unit and Single Use Global Business Unit
Deanna Johnston, VP Officer
John Marsden, Senior Vice President of Global Operations
BS MBA, APAC EMEA
Michael Gilleece, Senior Vice President Corporate General Counsel
Michael Evans, Director Relation
MS MA, Pres Unit
Amanda Manzoni, Chief Officer

Ansell Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Ansell a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Ansell Pink Sheet

Ansell financial ratios help investors to determine whether Ansell Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ansell with respect to the benefits of owning Ansell security.